These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15814434)

  • 21. Adhesion mechanisms in platelet function.
    Ruggeri ZM; Mendolicchio GL
    Circ Res; 2007 Jun; 100(12):1673-85. PubMed ID: 17585075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A bacterial ecto-triphosphate diphosphohydrolase similar to human CD39 is essential for intracellular multiplication of Legionella pneumophila.
    Sansom FM; Newton HJ; Crikis S; Cianciotto NP; Cowan PJ; d'Apice AJ; Hartland EL
    Cell Microbiol; 2007 Aug; 9(8):1922-35. PubMed ID: 17388784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of platelets in hemostasis and thrombosis.
    Day HJ
    Ser Haematol; 1975; 8(3):23-37. PubMed ID: 1234384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet function in intravascular device implant-induced intimal injury.
    Tesfamariam B
    Cardiovasc Revasc Med; 2008; 9(2):78-87. PubMed ID: 18486081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endotoxemia alters nucleotide hydrolysis in platelets of rats.
    Vuaden FC; Furstenau CR; Savio LE; Sarkis JJ; Bonan CD
    Platelets; 2009 Mar; 20(2):83-9. PubMed ID: 19235049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostacyclin/thromboxane-mediated mechanisms in platelet-vascular wall interactions.
    Moncada S
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():507-12. PubMed ID: 2936156
    [No Abstract]   [Full Text] [Related]  

  • 28. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis.
    Glenn JR; White AE; Johnson AJ; Fox SC; Myers B; Heptinstall S
    Platelets; 2008 Feb; 19(1):59-69. PubMed ID: 18231939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary haemostasis and its assessment by laboratory tests.
    Reininger AJ
    Hamostaseologie; 2006 Jan; 26(1):42-4, 46-7. PubMed ID: 16444321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of microvascular thromboembolism in vivo.
    Egbrink MG; Van Gestel MA; Broeders MA; Tangelder GJ; Heemskerk JM; Reneman RS; Slaaf DW
    Microcirculation; 2005; 12(3):287-300. PubMed ID: 15814437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
    de Meirelles LR; Mendes-Ribeiro AC; Santoro MM; Mendes MA; da Silva MN; Mann GE; Brunini TM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Coagulation activity of platelets].
    Reininger AJ
    Hamostaseologie; 2007 Sep; 27(4):247-50. PubMed ID: 17938762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose folate may improve platelet function in acute coronary syndrome and other pathologies associated with increased platelet oxidative stress.
    McCarty MF
    Med Hypotheses; 2007; 69(1):12-9. PubMed ID: 17293058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism triggering platelet hemostatic plug formation in vivo.
    Sakon M; Hawiger J
    Trans Assoc Am Physicians; 1984; 97():311-8. PubMed ID: 6535347
    [No Abstract]   [Full Text] [Related]  

  • 35. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
    Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet inhibitors and monitoring platelet function: implications for bleeding.
    Shore-Lesserson L
    Hematol Oncol Clin North Am; 2007 Feb; 21(1):51-63. PubMed ID: 17258118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemostatic and signaling functions of transfused platelets.
    Cauwenberghs S; van Pampus E; Curvers J; Akkerman JW; Heemskerk JW
    Transfus Med Rev; 2007 Oct; 21(4):287-94. PubMed ID: 17900490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of platelet function: does it offer a chance of better cancer progression control?
    Sierko E; Wojtukiewicz MZ
    Semin Thromb Hemost; 2007 Oct; 33(7):712-21. PubMed ID: 18000800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet regulation by NO/cGMP signaling and NAD(P)H oxidase-generated ROS.
    Begonja AJ; Teichmann L; Geiger J; Gambaryan S; Walter U
    Blood Cells Mol Dis; 2006; 36(2):166-70. PubMed ID: 16469512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles.
    Petrides PE; Siegel F
    Blood Cells Mol Dis; 2006; 36(3):379-84. PubMed ID: 16563815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.